Business Description
CHO Pharma Inc
ISIN : TW0006586001
Total Employee Number:
38Description
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 267.47 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 135.11 | |||||
Beneish M-Score | -3.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 8.8 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year FCF Growth Rate | 1.1 | |||||
3-Year Book Growth Rate | 14 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.97 | |||||
9-Day RSI | 48.54 | |||||
14-Day RSI | 50.26 | |||||
3-1 Month Momentum % | 90.26 | |||||
6-1 Month Momentum % | 378.93 | |||||
12-1 Month Momentum % | 235.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 21.96 | |||||
Quick Ratio | 21.96 | |||||
Cash Ratio | 21.25 | |||||
Days Sales Outstanding | 91.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | 0.06 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.45 | |||||
Operating Margin % | -17694.31 | |||||
Net Margin % | -15720.88 | |||||
EBITDA Margin % | -14309.74 | |||||
FCF Margin % | -14790.56 | |||||
OCF Margin % | -14149.79 | |||||
ROE % | -10.77 | |||||
ROA % | -10.33 | |||||
ROIC % | -64.73 | |||||
3-Year ROIIC % | -38.04 | |||||
ROC (Joel Greenblatt) % | -1105.89 | |||||
ROCE % | -10.75 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 14312.5 | |||||
PB Ratio | 10.33 | |||||
Price-to-Tangible-Book | 12.54 | |||||
EV-to-EBIT | -84.22 | |||||
EV-to-EBITDA | -92.43 | |||||
EV-to-Revenue | 13226.56 | |||||
EV-to-FCF | -89.43 | |||||
| Price-to-Net-Current-Asset-Value | 12.67 | |||||
| Price-to-Net-Cash | 13.12 | |||||
Earnings Yield (Greenblatt) % | -1.19 | |||||
FCF Yield % | -1.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CHO Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1.705 | ||
| EPS (TTM) (NT$) | -1.26 | ||
| Beta | -1.4883 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 1.35 | ||
| Volatility % | 140.56 | ||
| 14-Day RSI | 50.26 | ||
| 14-Day ATR (NT$) | 8.88354 | ||
| 20-Day SMA (NT$) | 116.15 | ||
| 12-1 Month Momentum % | 235.12 | ||
| 52-Week Range (NT$) | 22.75 - 148.5 | ||
| Shares Outstanding (Mil) | 214.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CHO Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CHO Pharma Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CHO Pharma Inc Frequently Asked Questions
What is CHO Pharma Inc(ROCO:6586)'s stock price today?
The current price of ROCO:6586 is NT$114.50. The 52 week high of ROCO:6586 is NT$148.50 and 52 week low is NT$22.75.
When is next earnings date of CHO Pharma Inc(ROCO:6586)?
The next earnings date of CHO Pharma Inc(ROCO:6586) is .
Does CHO Pharma Inc(ROCO:6586) pay dividends? If so, how much?
CHO Pharma Inc(ROCO:6586) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CHO Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers